Navigation Links
Ortho Biotech Announces NDA Submission for Trabectedin for the Treatment of Relapsed Ovarian Cancer
Date:11/20/2008

he ET743-OVA-301 Study

Patients were enrolled at 124 centers in 21 countries. Per the study protocol, the data were evaluated by a blinded, independent radiology review and a blinded, independent oncology review. The trabectedin/DOXIL combination demonstrated a statistically significant improvement in PFS compared to DOXIL alone (median PFS 7.3 versus 5.8 months, respectively) and a statistically significant reduction of 21% in the risk of progression or death during the observation period in the independent review of patients with radiologically measurable disease (HR=0.79, 95% CI (0.65;0.96), p=0.0190). This result is consistent with the results of the independent oncology review that takes into account clinical as well as imaging data in the assessment of progression. In this review, there was a 28% risk reduction for disease progression or death with the trabectedin/DOXIL combination (HR=0.72, 95% CI (0.60; 0.88), p=0.0008).

Secondary endpoints included response rate, overall survival, and safety. A statistically significant increase in response rate was seen with the trabectedin and DOXIL combination (28%) compared to DOXIL alone (19%), as measured by the independent radiology review. A final protocol-specified survival analysis is planned after the occurrence of 520 events. The safety profile in the study was consistent with previous experience with trabectedin and DOXIL.

The most common adverse reactions (greater than or equal to 20%) for the trabectedin/DOXIL combination compared to DOXIL alone, respectively, were:

  • Hematological reactions including neutropenia (77% versus 38%, with febrile neutropenia occurring in 8% of the cases and sepsis in 1% of the cases), leucopenia (48% versus 26%), anemia (48% versus 25%) and thrombocytopenia (36% versus 8%);
  • Gastrointestinal reactions including nausea (74% versus 42%), vomiting (56% versus 30%) and d
    '/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. New Orthopedic Oncology Fellowship Program at Mount Clemens Brings Highly Trained Surgeons to State
2. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
3. Dental Implants Effective for Orthodontic Treatment
4. Hanger Orthopedic Group, Inc. Receives Favorable New Code for WalkAide
5. Zimmer Holdings to Collaborate with the American Orthopaedic Association for Funding Post-Graduate Medical Education
6. Dr. Ron Greenspan has Been Selected for the 2008 Best of San Diego Award in the Orthodontists Category by the U.S. Local Business Association
7. Orthodontists Offer Sweet Incentives for Tricky Halloween Treats
8. Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008
9. Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
10. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
11. Amy Street, Certified Prosthetist and Orthotist, Joins BridgePoint Medical Partner, Charlotte Orthotic and Prosthetic Center (COPC)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... to scans performed in 2007 , , MONDAY, Dec. 14 ... to far more radiation than previously thought and in doses ... two new studies claim. , Based on the findings, reported ... Internal Medicine , the study authors, joined by Archives ... to limit radiation exposure to patients. , "CT has become ...
(Date:12/14/2009)... 2 diabetes and obesity are linked to an increased ... that insulin glargine (a synthetic insulin preparation marketed under ... higher risk of certain cancers than other insulins or ... unable to control for important factors such as obesity ... the other hand, a large randomized trial designed to ...
(Date:12/14/2009)... report cites lower rates for meth and smoking, ... Dec. 14 (HealthDay News) -- Fewer teenagers are ... stalled and abuse of prescription drugs remains high, ... said that newer drugs, such as the hallucinogenic ... is intended for treatment of attention-deficit hyperactivity disorder ...
(Date:12/14/2009)... Congress to Ensure Health Workforce Recommendations are ... -- Congressional leaders must ensure that health ... with sufficient authority to ensure implementation of ... according to Dr. Steven A Wartman, president ... Health Centers (AAHC). "With each step ...
(Date:12/14/2009)... is a statement of Matthew L. Myers, President, ... ) ,, The 2009 Monitoring the Future Survey ... Abuse shows that the nation continues to make ... have slowed significantly compared to the dramatic gains ... news, the survey also finds that smokeless tobacco ...
Breaking Medicine News(10 mins):Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 2Health News:Marijuana Use No Longer Dropping Among U.S. Teens 3Health News:Marijuana Use No Longer Dropping Among U.S. Teens 4Health News:Health Reform Needs Enforceable National Workforce Strategy 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 2Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 3Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 4Health News:New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts 5
... research conducted to study food service policy acceptance in ... difference between principals' and foodservice directors' perceptions. // ... highlight the need for communication among key stakeholders addressing ... and WIC Reauthorization Act of 2004. ...
... raise its investments in Scotland which is seen to ... Biocon is reported to already have // ... There are more than 550 life sciences organizations in ... to fill the gaps seen in India, according to ...
... result of breast-feeding, according to a Caroline Chantry led research ... group of 6 years to 24 months were studied during ... groups, formula-fed only, full breastfeeding for less than one month, ... four to less than six months, and full breastfeeding for ...
... of Madhya Pradesh has been chained to a post for the ... most of time in a motionless state, according to his family ... well as other villagers without any reason, says his brother Bhogchand, ... to get him treated, but this did not serve its purpose, ...
... MMR Triple Vaccine has found prominence again, for the wrong reasons. ... Peter Fletcher, who // held the post of Chief ... of not examining the risks of MMR triple vaccine adequately, despite ... According to him, if this doubt is proved, it could turn ...
... meant for treating HIV patients also served to protect monkeys ... same can be applied to human beings also has not ... ,Rhesus monkeys were experimented upon by the Centers ... with a version of the Truvada, manufactured by Gilead Sciences. ...
Other Medicine News:Health News:Clash of Difference of perceptions in food policy among Principals’ and Director 2
(Date:12/14/2009)... Seven leading cancer physicians ... Oncology Research participated in studies ... 2009 San Antonio Breast Cancer ... the Henry B. Gonzalez Convention ... . Fifteen others presented their ...
(Date:12/14/2009)... -- Perry Baromedical, international leader in Hyperbaric Chamber ... the Sigma Elite, with extended patient data capture ... is available on each monoplace chamber model currently ... Pending. ,, The Sigma Elite New "Smart Hyperbaric ... System for Each Dive Electronic (EMR) ...
(Date:12/14/2009)... CHICAGO, Dec. 14 Sword Diagnostics, Inc. ... Patent Office (USPTO) has issued patent number ... Biological Organisms using Raman Scattering" to the company. ... on improved sensitivity. ,, "The issuance of ... move forward with our continued development and commercialization," ...
Breaking Medicine Technology:US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 2US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 3US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 4US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 5US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 6US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 7US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 8US Oncology Research Network Participates in Seven Oral Clinical Studies Presentations and 15 Posters at 2009 San Antonio Breast Cancer Symposium 9Perry Baromedical Announces New Cutting Edge Technology With Patient Data Capture Capability 2Pelosi 3A Food Safety Act Will Protect Lives and Prevent Illness 53308 1GMA Applauds U S House for Passage of Landmark Food Safety Bill 53305 1GMA Applauds U S House for Passage of Landmark Food Safety Bill 53305 2British Woman Celebrates a Year of Living Cancer Free 4803 1British Woman Celebrates a Year of Living Cancer Free 4803 2British Woman Celebrates a Year of Living Cancer Free 4803 3British Woman Celebrates a Year of Living Cancer Free 4803 4
... Australia, Jan. 22 A new world-first study,by ... has a,profound impact on one of society,s biggest ... today in Journal of the American Medical,Association (JAMA), ... underwent,gastric banding were five times more likely to ...
... Contracts Give Access to Diagnostic Application of Research ... Coulter,Inc. (NYSE: BEC ) announced today that ... Ireland, Galway (NUI Galway) to direct assay,research and ... of infectious disease tests for the company,s future ...
Other Medicine Technology:Gastric Banding Reverses Impact of Type 2 Diabetes 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 2Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: